Michelle Lofwall is a Psychiatry physician affiliated with University of Kentucky. OpenAlex indexes 200 publications with 5,299 citations (h-index 40); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
845 Angliana Ave
Lexington, KY 405083146
Telephone
859-323-9321Registry record last updated 26 Mar 2019.
Clinical trials
- Efficacy of Extended Release Tramadol for Treating Prescription Opioid Withdrawal
Sponsor: Michelle Lofwall
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Braeburn Inc.Program year20252 payments
- Braeburn Inc.Program year20242 payments
- Braeburn Inc.Program year20235 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Partial Opioid Agonist100%Buprenorphine-Naloxone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2009–2023 per NIH RePORTER. The latest:
- DAT- Integrated Outpatient Treatment of Opioid Use Disorder and Injection-Related Infections
University of Kentucky
FY2023$664,716R01DA048892 - DAT- Integrated Outpatient Treatment of Opioid Use Disorder and Injection-Related Infections
University of Kentucky
FY2022$700,065R01DA048892 - DAT- Integrated Outpatient Treatment of Opioid Use Disorder and Injection-Related Infections
University of Kentucky
FY2021$711,945R01DA048892
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The policy landscape for naloxone distribution in four states highly impacted by fatal opioid overdoses
Drug and Alcohol Dependence Reports
2022
Similar KOLs
Other experts from the same institution or the same specialty.
David Moliterno, MD
University of Kentucky
Robert Dipaola
University of Kentucky
Darwin Conwell, MD
University of Kentucky
Phillip Tibbs
University of Kentucky
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”